Nuveen
BBNX

Nuveen’s Beta Bionics BBNX Stock Holding History

Nuveen’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43M Buy
91,371
+5,443
+6% +$64.7K ﹤0.01% 2755
2026
Q1 		$861K Buy
85,928
+549
+0.6% +$8.12K ﹤0.01% 2649
2025
Q4 		$2.6M Buy
85,379
+31,889
+60% +$852K ﹤0.01% 2178
2025
Q3 		$1.06M Buy
53,490
+36,446
+214% +$640K ﹤0.01% 2598
2025
Q2 		$248K Hold
17,044
– – ﹤0.01% 3109
2025
Q1 		$209K Buy
+17,044
New +$318K ﹤0.01% 3127

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Nuveen's BBNX Position: Q2 2026 in Review

Nuveen increased its Beta Bionics (BBNX) stake by 6.3% in Q2 2026, buying an estimated $64.7K and bringing the position to 91,371 shares worth $1.43M. The position accounts for ﹤0.01% of the portfolio, ranked #2755.

Nuveen first reported a position in BBNX in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.6M in Q4 2025. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Nuveen held 91,371 shares of Beta Bionics worth $1.43M as of Q2 2026.
  • Nuveen bought 5,443 Beta Bionics shares in Q2 2026, an estimated $64.7K.
  • Beta Bionics made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2755 holding.
  • Nuveen first reported a position in Beta Bionics in Q1 2025 and has held it in 6 quarters since.
  • Nuveen's Beta Bionics position peaked at $2.6M in Q4 2025.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.